PHARMACY CARE DOXYLAMINE SLEEP doxylamine succinate 25 mg tablet blister pack (New Formulation)

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

doxylamine succinate, Quantity: 25 mg

Available from:

Cipla Australia Pty Ltd

INN (International Name):

doxylamine succinate

Pharmaceutical form:

Tablet, uncoated

Composition:

Excipient Ingredients: microcrystalline cellulose; maize starch; lactose monohydrate; magnesium stearate; purified water

Administration route:

Oral

Units in package:

20

Prescription type:

(S3) Pharmacist Only Medicine

Therapeutic indications:

For temporary relief of sleeplessness

Product summary:

Visual Identification: white to off white, circular, biconvex uncoated tablets, central breakline on one side and plain on; Container Type: Blister Pack; Container Material: PVC/PE/PVDC/Al; Container Life Time: 24 Months; Container Temperature: Store below 30 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Authorization status:

Licence status A

Authorization date:

2015-03-03